These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29524130)

  • 1. Generation of TALE-Based Designer Epigenome Modifiers.
    Nitsch S; Mussolino C
    Methods Mol Biol; 2018; 1767():89-109. PubMed ID: 29524130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.
    Waryah CB; Moses C; Arooj M; Blancafort P
    Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors.
    Fang Y; Stroukov W; Cathomen T; Mussolino C
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Construction, and Application of Transcription Activation-Like Effectors.
    Deng P; Carter S; Fink K
    Methods Mol Biol; 2019; 1937():47-58. PubMed ID: 30706389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of Transcription Activator-Like Effectors in Xanthomonas oryzae.
    Erkes A; Reschke M; Boch J; Grau J
    Genome Biol Evol; 2017 Jun; 9(6):1599-1615. PubMed ID: 28637323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. dCas9: A Versatile Tool for Epigenome Editing.
    Brocken DJW; Tark-Dame M; Dame RT
    Curr Issues Mol Biol; 2018; 26():15-32. PubMed ID: 28879853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of Designer Epigenome Modifiers into Primary Human T Cells.
    Mlambo T; Romito M; Cornu TI; Mussolino C
    Methods Mol Biol; 2018; 1767():189-203. PubMed ID: 29524135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells.
    Mlambo T; Nitsch S; Hildenbeutel M; Romito M; Müller M; Bossen C; Diederichs S; Cornu TI; Cathomen T; Mussolino C
    Nucleic Acids Res; 2018 May; 46(9):4456-4468. PubMed ID: 29538770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.
    Sen D; Keung AJ
    Methods Mol Biol; 2018; 1767():65-87. PubMed ID: 29524129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TALEored Epigenetics: A DNA-Binding Scaffold for Programmable Epigenome Editing and Analysis.
    Kubik G; Summerer D
    Chembiochem; 2016 Jun; 17(11):975-80. PubMed ID: 26972580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for Efficient Generation of Chimeric Antigen Receptor T Cells with Multiplexed Gene Silencing by Epigenome Editing.
    Azcona MSR; Mussolino C
    Methods Mol Biol; 2024; 2842():209-223. PubMed ID: 39012598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified nucleobase-specific gene regulation using engineered transcription activator-like effectors.
    Tsuji S; Imanishi M
    Adv Drug Deliv Rev; 2019 Jul; 147():59-65. PubMed ID: 31513826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Toolboxes for Precision Genome/Epigenome Editing and Imaging of Epigenetics.
    Nomura W
    Chem Rec; 2018 Dec; 18(12):1717-1726. PubMed ID: 30066981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenome Editing in the Brain.
    Bashtrykov P; Jeltsch A
    Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of IL12B Expression in Human Macrophages by TALEN-mediated Epigenome Editing.
    Chen M; Zhu H; Mao YJ; Cao N; Yu YL; Li LY; Zhao Q; Wu M; Ye M
    Curr Med Sci; 2020 Oct; 40(5):900-909. PubMed ID: 33123904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering TAL effectors for 5-methylcytosine and 5-hydroxymethylcytosine recognition.
    Zhang Y; Liu L; Guo S; Song J; Zhu C; Yue Z; Wei W; Yi C
    Nat Commun; 2017 Oct; 8(1):901. PubMed ID: 29026078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing the Epigenome: Overview, Open Questions, and Directions of Future Development.
    Rots MG; Jeltsch A
    Methods Mol Biol; 2018; 1767():3-18. PubMed ID: 29524127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Application of DNA Modification-Specific Transcription-Activator-Like Effectors.
    Buchmuller B; Muñoz-López Á; Gieß M; Summerer D
    Methods Mol Biol; 2021; 2198():381-399. PubMed ID: 32822046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
    Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T
    Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression.
    Seem K; Kaur S; Kumar S; Mohapatra T
    Crit Rev Biochem Mol Biol; 2024; 59(1-2):69-98. PubMed ID: 38440883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.